Advancing PROTAC Discovery Through SLIP: Identifying Degradation Effector Sites for Targeted Therapeutics
Time: 3:45 pm
day: Day 1, PM
Details:
- Addressing the need for more TPD effectors and their ligands to expand the therapeutic potential of protein degradation
- Introducing SLIP, a cutting-edge platform that enables the creation of proximity in live cells, enhancing the discovery of new degradation pathways
- Demonstrating how SLIP has successfully identified PROTAC-able sites on key TPD effectors, paving the way for the development of next-generation targeted therapies
